Literature DB >> 20177701

Progressive cerebellar degenerative changes in the severe mental retardation syndrome caused by duplication of MECP2 and adjacent loci on Xq28.

William Reardon1, Veronica Donoghue, Anne-Marie Murphy, Mary D King, Philip D Mayne, Nina Horn, Lisbeth Birk Møller.   

Abstract

Localised duplications, involving the MECP2 locus, at Xq28 have been associated with a syndrome comprising X-linked mental retardation, hypotonia and recurrent infections in males. We now present neuroradiological evidence that progressive cerebellar degenerative changes may also be a consistent feature of this syndrome, emerging in the second decade of life. We report seven affected males, from three different families who, in addition to the previously described clinical findings, have a reduction in the volume of the white matter and mild dilatation of the lateral ventricles. Three of the older patients show a consistent cerebellar degenerative phenotype. Furthermore, we describe the first female affected with the disorder. The female was mildly affected and shows X-inactivation in the ratio of 70:30, demonstrating that X-inactivation cannot be exclusively relied upon to spare the female carriers from symptoms. In conclusion, there is a radiological phenotype associated with Xq28 duplication which clearly demonstrates progressive degenerative cerebellar disease as part of the syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20177701     DOI: 10.1007/s00431-010-1144-4

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  XLMR syndrome characterized by multiple respiratory infections, hypertelorism, severe CNS deterioration and early death localizes to distal Xq28.

Authors:  H Lubs; F Abidi; J A Bier; D Abuelo; L Ouzts; K Voeller; E Fennell; R E Stevenson; C E Schwartz; F Arena
Journal:  Am J Med Genet       Date:  1999-07-30

Review 2.  X linked mental retardation: a clinical guide.

Authors:  F L Raymond
Journal:  J Med Genet       Date:  2005-08-23       Impact factor: 6.318

3.  Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome.

Authors:  M Meins; J Lehmann; F Gerresheim; J Herchenbach; M Hagedorn; K Hameister; J T Epplen
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

4.  Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males.

Authors:  Hilde Van Esch; Marijke Bauters; Jaakko Ignatius; Mieke Jansen; Martine Raynaud; Karen Hollanders; Dorien Lugtenberg; Thierry Bienvenu; Lars Riff Jensen; Jozef Gecz; Claude Moraine; Peter Marynen; Jean-Pierre Fryns; Guy Froyen
Journal:  Am J Hum Genet       Date:  2005-07-29       Impact factor: 11.025

5.  Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients.

Authors:  H L Archer; S D Whatley; J C Evans; D Ravine; P Huppke; A Kerr; D Bunyan; B Kerr; E Sweeney; S J Davies; W Reardon; J Horn; K D MacDermot; R A Smith; A Magee; A Donaldson; Y Crow; G Hermon; Z Miedzybrodzka; D N Cooper; L Lazarou; R Butler; J Sampson; D T Pilz; F Laccone; A J Clarke
Journal:  J Med Genet       Date:  2005-09-23       Impact factor: 6.318

6.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.

Authors:  R E Amir; I B Van den Veyver; M Wan; C Q Tran; U Francke; H Y Zoghbi
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

7.  Neurologic aspects of MECP2 gene duplication in male patients.

Authors:  Bernard Echenne; Agathe Roubertie; Dorien Lugtenberg; Titske Kleefstra; Ben C J Hamel; Hans Van Bokhoven; Didier Lacombe; Christophe Philippe; Philippe Jonveaux; Arjan P M de Brouwer
Journal:  Pediatr Neurol       Date:  2009-09       Impact factor: 3.372

8.  Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28.

Authors:  Michael J Friez; Julie R Jones; Katie Clarkson; Herbert Lubs; Dianne Abuelo; Jo-Ann Blaymore Bier; Shashidhar Pai; Richard Simensen; Charles Williams; Philip F Giampietro; Charles E Schwartz; Roger E Stevenson
Journal:  Pediatrics       Date:  2006-11-06       Impact factor: 7.124

9.  Neonatal encephalopathy in two boys in families with recurrent Rett syndrome.

Authors:  N C Schanen; T W Kurczynski; D Brunelle; M M Woodcock; L S Dure; A K Percy
Journal:  J Child Neurol       Date:  1998-05       Impact factor: 1.987

10.  Large deletions of the MECP2 gene detected by gene dosage analysis in patients with Rett syndrome.

Authors:  Franco Laccone; Ivonne Jünemann; Sharon Whatley; Rhian Morgan; Rachel Butler; Peter Huppke; David Ravine
Journal:  Hum Mutat       Date:  2004-03       Impact factor: 4.878

View more
  22 in total

1.  MECP2 Duplication Syndrome.

Authors:  H Van Esch
Journal:  Mol Syndromol       Date:  2011-07-05

2.  De novo MECP2 duplication in two females with random X-inactivation and moderate mental retardation.

Authors:  Ute Grasshoff; Michael Bonin; Ina Goehring; Arif Ekici; Andreas Dufke; Kirsten Cremer; Nicholas Wagner; Eva Rossier; Anna Jauch; Michael Walter; Claudia Bauer; Peter Bauer; Karl Horber; Stefanie Beck-Woedl; Dagmar Wieczorek
Journal:  Eur J Hum Genet       Date:  2011-02-16       Impact factor: 4.246

3.  De novo MECP2 duplications in two females with intellectual disability and unfavorable complete skewed X-inactivation.

Authors:  Nathalie Fieremans; Marijke Bauters; Stefanie Belet; Jelle Verbeeck; Anna C Jansen; Sara Seneca; Filip Roelens; Elfride De Baere; Peter Marynen; Guy Froyen
Journal:  Hum Genet       Date:  2014-07-19       Impact factor: 4.132

4.  Insights into the cellular and molecular contributions of MeCP2 overexpression to disease pathophysiology.

Authors:  M Morgan Taylor; Shachee Doshi
Journal:  J Neurosci       Date:  2012-07-11       Impact factor: 6.167

Review 5.  The impact of MeCP2 loss- or gain-of-function on synaptic plasticity.

Authors:  Elisa S Na; Erika D Nelson; Ege T Kavalali; Lisa M Monteggia
Journal:  Neuropsychopharmacology       Date:  2012-07-11       Impact factor: 7.853

6.  Isoform-specific toxicity of Mecp2 in postmitotic neurons: suppression of neurotoxicity by FoxG1.

Authors:  Somasish Ghosh Dastidar; Farah H Bardai; Chi Ma; Valerie Price; Varun Rawat; Pragya Verma; Vinodh Narayanan; Santosh R D'Mello
Journal:  J Neurosci       Date:  2012-02-22       Impact factor: 6.167

Review 7.  MECP2 disorders: from the clinic to mice and back.

Authors:  Laura Marie Lombardi; Steven Andrew Baker; Huda Yahya Zoghbi
Journal:  J Clin Invest       Date:  2015-08-03       Impact factor: 14.808

Review 8.  X-linked disorders with cerebellar dysgenesis.

Authors:  Ginevra Zanni; Enrico S Bertini
Journal:  Orphanet J Rare Dis       Date:  2011-05-15       Impact factor: 4.123

9.  Is autism a disease of the cerebellum? An integration of clinical and pre-clinical research.

Authors:  Tiffany D Rogers; Eric McKimm; Price E Dickson; Dan Goldowitz; Charles D Blaha; Guy Mittleman
Journal:  Front Syst Neurosci       Date:  2013-05-10

10.  A case report of Chinese brothers with inherited MECP2-containing duplication: autism and intellectual disability, but not seizures or respiratory infections.

Authors:  Xiu Xu; Qiong Xu; Ying Zhang; Xiaodi Zhang; Tianlin Cheng; Bingbing Wu; Yanhua Ding; Ping Lu; Jingjing Zheng; Min Zhang; Zilong Qiu; Xiang Yu
Journal:  BMC Med Genet       Date:  2012-08-21       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.